Xtampza ER
Commercial- Indications
- Pain management
Company intelligence / Profile preview
Curadel Surgical Innovations develops and commercializes advanced near-infrared fluorescent contrast agents using its proprietary FLARE® technology. Its lead product ZW800‑1 enables real-time intraoperative identification of the ureters to reduce surgical complications. The company’s pipeline includes additional targeted imaging agents and next-generation MRI contrast compounds. ZW800‑1 has reached Phase III pivotal trials with an exclusive distribution agreement in place with a major medical device partner.[2][6][9]
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Curadel Surgical Innovations, Inc..